Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia

Cancer Epidemiology

Volumn 36, Issue 3, 2012, Pages 298-302

  Brotherton, Julia M L ^a   Mullins, Robyn M ^b  

^a VICTORIAN CYTOLOGY SERVICE   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

Author keywords

Cervical cancer screening; Human papillomavirus

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; ATTITUDE TO HEALTH; AUSTRALIA; CANCER IMMUNIZATION; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SELF REPORT; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGE FACTORS; DATA COLLECTION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VICTORIA; YOUNG ADULT;

EID: 84860663518     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.11.005     Document Type: Article

References (21)

1. Canfell K., Sitas F., Beral V. Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality. The Medical Journal of Australia 2006, 185:482-486.
2. Kitchener H.C., Castle P.E., Cox J.T. Chapter 7: Achievements and limitation of cervical cytology screening. Vaccine 2006, 24S3. S3/63-70.
3. Li N., Franceschi S., Howell-Jones R., Snijders P.J., Clifford G.M. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 2011, 128(4). S3/927-35.
4. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., Clifford G.M. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007, 121. S3/621-32.
5. Lancucki L., Fender M., Koukari A., Lynge E., Mai V., et al. A fall-off in cervical screening coverage of younger women in developed countries. J Med Screen 2010, 17. S3/91-6.
6. Mullins R., Wakefield M., Broun K. Encouraging the right women to attend for cervical cancer screening: results from a targeted television campaign in Victoria, Australia. Health Educ Res 2008, 23. S3/477-86.
7. Hull B, Lawrence G, MacIntyre CR, McIntyre P. Immunisation coverage: Australia 2001. DOHA/Immunise Australia Program 2002, Canberra.
8. Gertig D.M., Brotherton J.M.L., Saville M. Methods for measuring HPV vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Sexual Health 2011, 8:171-178.
9. Brotherton J., Gertig D., Chappell G., Rowlands L., Saville M. Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18-26 years from the National HPV Vaccination Program Register. Commun Dis Intell 2011, 35(2):197-201.
10. Australian Bureau of Statistics 2006 Census of Population and Housing.
11. Brotherton J.M.L., Leask J., Jackson C., McCaffery K., Trevena L.J. National survey of the general practitioner's experience of delivering the National Human Papillomavirus Vaccination Program. Sexual Health 2010, 7:291-298.
12. Anhang Price R, Koshiol J, Kobrin S, Tiro JA. Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine. Vaccine, doi:10.1016/j.vaccine.2011.03.076.
13. Paul-Ebhohimhen V., Huc S., Tissingtoin H., Oates K., Stark C. HPV vaccination: vaccine acceptance, side effects and screening intentions. Commun Pract 2010, 83(6):30-33.
14. Bauch C.T., Li M., Chapman G., Galvani A.P. Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low?. Lancet Infect Dis 2010, 10:133-137.
15. Kulasingam S.L., Pagliusi S., Myers E. Potential effects of decreased cervical cancer screening participation after HPV vaccination: an example from the US. Vaccine 2007, 25:8110-8113.
16. Australian Institute of Health and Welfare Cervical screening in Australia 2007-2008: data report 2010, AIHW, Canberra, Cancer series no. 54. Cat. no. CAN 50.
17. Victorian Cervical Cytology Registry. Victorian Cervical Cytology Registry Statistical Report 2009. [accessed 23.06.11]. http://www.vccr.org/stats.html.
18. Brotherton J.M.L., Kaldor J.M., Garland S.M. Human papillomavirus (HPV) surveillance in Australia: what are the building blocks required for a comprehensive monitoring system?. Sexual Health 2010, 7:310-319.
19. Franco E.L., Mahmud S.M., Tota J., Ferenczy A., Coutlée F. The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change. Arch Med Res 2009, 40(6):478-485.
20. Dillner J., Rebolj M., Birembaut P., et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 2008, 337:a1754. 10.1136/bmj.a1754.
21. Creighton P., Lew J.-B., Clements M., Smith M., Howard K., Dyer S., Lord S., Canfell K., et al. Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years. BMC Public Health 2010, 10:734. http://www.biomedcentral.com/1471-2458/10/734.